Moreover, it has been argued that placebo-neurofeedback training is not feasible since it is clearly recognized by the patient (Kotchoubey et al. 2001).In addition to a placebo-controlled design, it is important to monitor adverse events such as headaches and sleep problems, structurally during the training period to test the safety of (placebo)-neurofeedback training.